The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

MR Minter, JM Taylor, PJ Crack - Journal of neurochemistry, 2016 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disease and the most
common cause of dementia. Deposition of amyloid‐β (Aβ) remains a hallmark feature of the …

Do STAT3 inhibitors have potential in the future for cancer therapy?

ALA Wong, JL Hirpara, S Pervaiz, JQ Eu… - Expert opinion on …, 2017 - Taylor & Francis
Signal transduction activator of transcription (STAT) 3 is a member of the STAT protein family
which transduces intracellular and extracellular signals to the nucleus, controlling the …

Quinones as neuroprotective agents

Á Cores, N Carmona-Zafra, J Clerigué, M Villacampa… - Antioxidants, 2023 - mdpi.com
Quinones can in principle be viewed as a double-edged sword in the treatment of
neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic …

TYK2 regulates tau levels, phosphorylation and aggregation in a tauopathy mouse model

J Kim, B Tadros, YH Liang, Y Kim… - Nature …, 2024 - nature.com
Alzheimer's disease is one of at least 26 diseases characterized by tau-positive
accumulation in neurons, glia or both. However, it is still unclear what modifications cause …

STAT3 and apoptosis challenges in cancer

N Fathi, G Rashidi, A Khodadadi, S Shahi… - International journal of …, 2018 - Elsevier
Several studies have processed conceivable evidence for the vital role of Signal Transducer
and Activator of Transcription 3 (STAT3) in cancer transformation and carcinogenesis …

Cannabinoids alleviate the LPS-induced cytokine storm via attenuating NLRP3 inflammasome signaling and TYK2-mediated STAT3 signaling pathways in vitro

SV Suryavanshi, M Zaiachuk, N Pryimak, I Kovalchuk… - Cells, 2022 - mdpi.com
Cannabinoids, mainly cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), are the most
studied group of compounds obtained from Cannabis sativa because of their several …

Inflammation and Alzheimer's disease: mechanisms and therapeutic implications by natural products

MA Rather, A Khan, S Alshahrani… - Mediators of …, 2021 - Wiley Online Library
Alzheimer's disease (AD) is a neurodegenerative disorder with no clear causative event
making the disease difficult to diagnose and treat. The pathological hallmarks of AD include …

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease

K Ceyzériat, L Ben Haim, A Denizot, D Pommier… - Acta neuropathologica …, 2018 - Springer
Astrocyte reactivity and neuroinflammation are hallmarks of CNS pathological conditions
such as Alzheimer's disease. However, the specific role of reactive astrocytes is still …

Prospects for pharmacological targeting of pseudokinases

JE Kung, N Jura - Nature Reviews Drug Discovery, 2019 - nature.com
Pseudokinases are members of the protein kinase superfamily but signal primarily through
noncatalytic mechanisms. Many pseudokinases contribute to the pathologies of human …

Cdk5: a multifaceted kinase in neurodegenerative diseases

ZH Cheung, NY Ip - Trends in cell biology, 2012 - cell.com
Since the identification of cyclin-dependent kinase-5 (Cdk5) as a tau kinase and member of
the Cdk family almost 20 years ago, deregulation of Cdk5 activity has been linked to an …